Neuphoria Therapeutics (NEUP) EPS (Basic) (2023 - 2026)
Neuphoria Therapeutics (NEUP) posted quarterly EPS (Basic) of -$0.09 for Q1 2026, down 101.42% year-over-year from $6.55 in Q1 2025, and down 122.71% quarter-over-quarter from $0.41 in Q4 2025.
Neuphoria Therapeutics (NEUP) EPS (Basic) (2023 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has reported EPS (Basic) for 4 consecutive years, with -$0.09 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 101.42% year-over-year to -$0.09; the TTM figure through Mar 2026 stood at -$1.99 (down 155.28% YoY), while the FY2025 annual figure was $3.87, up 3929.8% from the prior year.
- EPS (Basic) declined to -$0.09 in Q1 2026 per NEUP's latest filing, from $0.41 in the prior quarter.
- Across five years, EPS (Basic) topped out at $6.55 in Q1 2025 and bottomed at -$5.31 in Q4 2023.
- Historically, EPS (Basic) has averaged -$0.76 across 4 years, with a median of -$0.09 in 2026.
- On a YoY basis, EPS (Basic) climbed as much as 331.34% in 2025 and fell as far as 128144.04% in 2025.
- Neuphoria Therapeutics' EPS (Basic) stood at -$5.31 in 2023, then soared by 76.78% to -$1.23 in 2024, then jumped by 133.31% to $0.41 in 2025, then sank by 122.71% to -$0.09 in 2026.
- Business Quant data shows NEUP's EPS (Basic) at -$0.09 in Q1 2026, $0.41 in Q4 2025, and -$4.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.18 |
| 10 | Neuphoria Therapeutics | 21.37 Mn | 1.93 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | -4.41 |
| Jun 30, 2025 | -1.38 |
| Mar 31, 2025 | 6.55 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -2.83 |
| Dec 31, 2023 | -5.31 |
| Sep 30, 2023 | -0.04 |